{
    "eid": "2-s2.0-85007583353",
    "title": "Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway",
    "cover-date": "2017-06-01",
    "subject-areas": [
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Hematology",
            "@code": "2720"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [],
    "authors": [
        "Y. Shen"
    ],
    "citedby-count": 29,
    "ref-count": 60,
    "ref-list": [
        "Acute lymphoblastic leukaemia",
        "Biology, risk stratification, and therapy of pediatric acute leukemias: An update",
        "Treatment of acute lymphoblastic leukemia",
        "Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A therapeutic advances in childhood leukemia consortium study",
        "Notch signaling in leukemia",
        "Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia",
        "Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia",
        "The molecular basis of T cell acute lymphoblastic leukemia",
        "Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia",
        "The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene",
        "KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma",
        "Kr\u00fcppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma",
        "KLF4 translation level is associated with differentiation stage of different pediatric leukemias in both cell lines and primary samples",
        "CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPAR\u03b3 signaling",
        "Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma",
        "Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia",
        "MiR-2909-mediated regulation of KLF4: A novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias",
        null,
        null,
        "The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells",
        "Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia",
        "Kruppel like factor 4 promoter undergoes active demethylation during monocyte/macrophage differentiation",
        "Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis",
        "DNA methylation of the first exon is tightly linked to transcriptional silencing",
        "Klf4 is a transcription factor required for establishing the barrier function of the skin",
        "Kr\u00fcppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen",
        "Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles",
        "TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms",
        "The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21(WAF1)/(Cip)1 promoter",
        null,
        "Kr\u00fcppel-like factor 4 prevents centrosome amplification following \u03b3-irradiation-induced DNA damage",
        null,
        "Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia",
        "ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays",
        "XThe ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability",
        "Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse",
        "Discovery of potent and selective covalent inhibitors of JNK",
        null,
        "SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase",
        "A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis",
        "Leukaemogenesis: More than mutant genes",
        "Genetic and epigenetic heterogeneity in acute myeloid leukemia",
        "Kr\u00fcppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling",
        "Dna methylation-based subtype prediction for pediatric acute lymphoblastic leukemia",
        "Promoter DNA Methylation Pattern Identifies Prognostic Subgroups in Childhood T-Cell Acute Lymphoblastic Leukemia",
        "Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression",
        "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors",
        "Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion",
        "The bottleneck of JNK signaling: Molecular and functional characteristics of MKK4 and MKK7",
        null,
        "High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model",
        "Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors",
        "The roles of ATF2 (activating transcription factor 2) in tumorigenesis",
        "Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes",
        "JNK is required for effector T-cell function but not for T-cell activation",
        "Defective T cell differentiation in the absence of Jnk1",
        "JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development",
        null,
        "Targeting JNK for therapeutic benefit: From junk to gold?",
        "The synergistic repressive effect of NF-\u03baB and JNK inhibitor on the clonogenic capacity of jurkat leukemia cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rotterdam",
            "affilname": "Erasmus MC Sophia Children\u2019s Hospital",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Houston",
            "affilname": "Texas Children's Hospital",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Harvard Medical School",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Houston",
            "affilname": "Baylor College of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Houston",
            "affilname": "Texas Children's Cancer and Hematology Centers",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}